Skip Navigation

Cardiovascular Research 2000 45(3):560-569; doi:10.1016/S0008-6363(99)00372-7
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Feuerstein, G. Z.
Right arrow Articles by Young, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feuerstein, G. Z.
Right arrow Articles by Young, P. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways

Giora Z. Feuerstein* and Peter R. Young

Cardiovascular Disease Research, DuPont Pharmaceuticals Corporation, Wilmington, DE 19880-0400, USA

* Corresponding author. Tel.: +1-302-695-1840; fax: +1-302-695-4162

Apoptosis is a form of cell death that involves discrete genetic and molecular programs, de novo protein expression and a unique cellular phenotype. Evidence for the existence of apoptosis in the human heart has been reported in various cardiac diseases, including ischemic and non-ischemic heart failure, myocardial infarction and arrhythmias. Among the most potent stimuli that elicit cardiomyocyte apoptosis are: oxygen radicals (including NO), cytokines (FAS/TNF{alpha}-receptor signaling), stress conditions (chemical or physical, e.g., radiation), sphingolipid metabolites (ceramide) and autocoids, e.g., angiotensin II. Apoptosis of cardiac myocytes may contribute to progressive pump-failure, arrhythmias and cardiac remodeling. The recognition of numerous molecular targets associated with cardiomyocyte apoptosis may provide novel therapeutic strategies for diverse cardiac ailments, as recently suggested by pharmacologic studies in experimental animals. This review paper is aimed to highlight the role of protein kinase signaling pathways in apoptosis with special attention to the stress-activated protein kinases (SAPK) and mitogen-activated protein kinases (MAPK) systems.

KEYWORDS Heart failure; Protein kinases; Signal transduction


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
K. Pramanik, C. Z. Chun, M. K. Garnaas, G. V. Samant, K. Li, M. A. Horswill, P. E. North, and R. Ramchandran
Dusp-5 and Snrk-1 coordinately function during vascular development and disease
Blood, January 29, 2009; 113(5): 1184 - 1191.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
W. Ibe, A. Saraste, S. Lindemann, S. Bruder, M. Buerke, H. Darius, K. Pulkki, and L.-M. Voipio-Pulkki
Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment
Eur J Heart Fail, February 1, 2007; 9(2): 160 - 167.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
A. Jekell, A. Hossain, U. Alehagen, U. Dahlstrom, and A. Rosen
Elevated circulating levels of thioredoxin and stress in chronic heart failure
Eur J Heart Fail, December 1, 2004; 6(7): 883 - 890.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.